Countermeasures
The Nuclear Threat Initiative (NTI), along with the World Institute for Nuclear Security (WINS), is holding a one-day workshop entitled “Radiological Security: Increasing Transparency and Voluntary Reporting” this week in Berlin.
The workshop serves as a key component to continued progress... Read More »
Aeolus Pharmaceuticals, Inc., recently released data confirming the efficacy of AEOL 10150 as a medical countermeasure against sulfur mustard gas inhalation.
Research for the study was conducted by Dr. Brian Day, vice chair of research at National Jewish Health, in collaboration with the U.S.... Read More »
INTERPOL recently conducted a series of cybercrime training sessions in Latin America and the Caribbean seeking to enhance regional law enforcement capacity to respond to and prevent cyberthreats.
The training efforts served as an important part of INTERPOL’s Cybercrime Capacity Building... Read More »
Sandia National Laboratories recently won the 2016 Federal Laboratory Consortium Award for Excellence in Technology for their efforts in the development of the x-ray toolkit (XTK) image processing and analysis software.
The XTK was developed in the wake of the 2013 Boston bombing incident that... Read More »
The U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) recently provided Takeda Vaccines, Inc., with a grant to develop a Zika virus vaccine.
The grant, worth $19.8 million, will be spaced out over the course of the next 18... Read More »
The Edgewood Chemical Biological Center (ECBC), along with private technology developers, recently tested a new integrated system of chemical and biological agent sensors at Dugway Proving Ground’s West Desert Test Center in Utah.
ECBC’s team worked to develop an unmanned aerial vehicle,... Read More »
Director General for the Organization for the Prohibition of Chemical Weapons (OPCW) Ahmet Üzümcü recently confirmed that the remaining chemical weapons stocks left in Libya have been successfully removed from the country.
The operation was facilitated in part by the OPCW in response to... Read More »
The U.S. government has become “somewhat complacent” in preparing for potential bioterrorist attacks and needs to implement a national biodefense strategy, Daniel Gerstein, a senior policy researcher at the nonpartisan RAND Corporation, recently told Homeland Preparedness News.
The anthrax... Read More »
More federal counterterrorism funding should be directed to local law enforcement agencies for human intelligence initiatives in urban areas where the risk of a terrorist attack is high, according to Matt Mayer, a homeland security expert at the American Enterprise Institute (AEI), recently told... Read More »
A collaborative research effort by the Johns Hopkins University School of Medicine, the National Institutes of Health and Florida State University recently revealed two classes of compounds already in use in the pharmaceutical industry that might prove useful in the fight against Zika virus.... Read More »
The Raytheon Company showcased its newest battle management tool on Monday at the U.S. Army’s Cyber Quest event.
Cyber and Electromagnetic Battle Management (CEMBM) integrates both cyber and electromagnetic spectrum awareness capabilities into the Army’s Electronic Warfare Program... Read More »
Researchers at the University of Texas Medical Branch (UTMB) released a study on Monday showing the successful treatment of monkeys infected with Sudan ebolavirus (SUDV) several days after infection.
Scientists have known about SUDV and Zaire ebolavirus (EBOV) since 1976, with EBOV being the... Read More »
The U.S. Food and Drug Administration (FDA) recently approved Emergent BioSolutions, Inc.’s supplemental Biologics License Application (sBLA) for the manufacture of BioThrax (Anthrax Vaccine Adsorbed) at the company’s large-scale Building 55 manufacturing facility in Lansing,... Read More »
The Defense Advanced Research Projects Agency (DARPA) issued a request for information (RFI) on Thursday for ways to improve the protection of fixed, mobile ground and naval forces against a variety of small unmanned air systems (sUAS) technologies.
“DARPA is interested in identifying novel,... Read More »
Soligenix, Inc., released information regarding its performance and accomplishments in the second quarter on Thursday.
“We continue to be very encouraged with the positive results demonstrated in our Phase 2 oral mucositis trial with SGX942 and expect to report long-term safety data during... Read More »
